𝔖 Bobbio Scriptorium

✦ LIBER ✦

P-603 Phase I results of RTOG L-0117; a phase i/II dose intensificationstudy using 3DCRT and concurrent chemotherapy for patients with inoperable NSCLC

✍ Scribed by Bradley, J.; Graham, M.; Swann, S.; Byhardt, R.; Govindan, R.; Fowler, J.; Purdy, J.; Michalski, J.; Gore, E.; Choy, H.

Book ID: 118573507
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 128 KB
Volume: 49
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(05)81096-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-603 Symptom response following high do

P-603 Symptom response following high dose (HD) palliative radiotherapy (RT) plus concurrent weekly vinorelbine (V) and cis-platinum (C) in patients with locally advanced and metastatic non-small cell lung cancer (NSCLC): Results of a phase-I study

✍ Wirth, Andrew; Michael, Michael; Ball, David; MacManus, Michael; Rischin, Danny; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Preliminary results of a phase II study

Preliminary results of a phase II study of neoadjuvant radiotherapy (RT) concurrent with weekly paclitaxel (P) and carboplatin (C), followed by surgery (S) in patients (pts) with stage IIB-IIIB non small cell lung cancer (NSCLC)

✍ A. Kuten; R. Abdah-Bortnyak; L. Chetver; I. Zen Al Deen; K. Daoud; R. Nijem; S. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 169 KB

A Novel High Dose Chemotherapy Strategy

A Novel High Dose Chemotherapy Strategy With Bendamustine in Adjunct to Etoposide, Cytarabine and Melphalan (BeEAM) Followed by Autologous Stem Cell Rescue Is Safe and Highly Effective for the Treatment of Resistant/Relapsed Lymphoma Patients: A Phase I-II Study on 44 Patients

✍ G. Visani; L. Malerba; P.M. Stefani; S. Capria; P. Galieni; F. Gaudio; G. Specch 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Long-term results of first-line sequenti

Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group: Schmoll HJ, Kollmannsberger C, Metzner B, Hartmann JT, Schleucher N, Schoffski P, Schleicher J, Rick O, Beyer J, Hossfeld D, Kanz L, Berdel WE, Andreesen R, Bokemeyer C, German Testicular Cancer Study Group, Department of Hematology/Oncology, University of Halle, Halle, Germany.

✍ Jerome P Richie 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 18 KB